2-氟-6-[4-(甲硫基)甲氧苯基]苄腈 | 148901-52-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-氟-6-[4-(甲硫基)甲氧苯基]苄腈
• 中文别名: 2-氟-6-[4-(甲基硫代)苯氧基]苯甲腈
• 英文名称: 2-fluoro-6-[(4-methylthio)phenoxy]benzonitrile
• 英文别名: 2-fluoro-6-[4-(methylthio)phenoxy]benzonitrile；2-fluoro-6-(4-methylsulfanylphenoxy)benzonitrile
• CAS: 148901-52-4
• 化学式: C₁₄H₁₀FNOS
• mdl: MFCD00068069
• 分子量: 259.304
• InChiKey: KIJMTRJIUKHLPE-UHFFFAOYSA-N

物化性质

• 熔点：
  68 °C
• 沸点：
  372.2±42.0 °C(Predicted)
• 密度：
  1.28±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  18
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.071
• 拓扑面积：
  58.3
• 氢给体数：
  0
• 氢受体数：
  4

安全信息

• 危险品标志：
  Xn
• 安全说明：
  S23,S36/37/39
• 危险类别码：
  R20/21/22
• 海关编码：
  2930909090

SDS

Name:	2-Fluoro-6-[4-(methylthio)phenoxy]benzonitrile 97% Material Safety Data Sheet
Synonym:
CAS:	148901-52-4

Section 1 - Chemical Product MSDS Name:2-Fluoro-6-[4-(methylthio)phenoxy]benzonitrile 97% Material Safety Data Sheet
Synonym:

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
148901-52-4	2-Fluoro-6-[4-(methylthio)phenoxy]benz	97%	unlisted

Hazard Symbols: XN
Risk Phrases: 20/21/22 36/37/38

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed.
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. Harmful if absorbed through the skin.
Ingestion:
Harmful if swallowed. May cause irritation of the digestive tract.
Inhalation:
Harmful if inhaled. Causes respiratory tract irritation.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

---

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 148901-52-4: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: white - off-white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 68 - 71 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C14H10FNOS
Molecular Weight: 259

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents, reducing agents.
Hazardous Decomposition Products:
Hydrogen cyanide, nitrogen oxides, carbon monoxide, oxides of sulfur, carbon dioxide, fluorine, hydrogen fluoride gas.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 148901-52-4 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
2-Fluoro-6-[4-(methylthio)phenoxy]benzonitrile - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: NITRILES, SOLID, TOXIC, N.O.S.*
Hazard Class: 6.1
UN Number: 3276
Packing Group: III
IMO
Shipping Name: NITRILES, TOXIC, N.O.S.
Hazard Class: 6.1
UN Number: 3276
Packing Group: III
RID/ADR
Shipping Name: NITRILES, TOXIC, N.O.S.
Hazard Class: 6.1
UN Number: 3276
Packing group: III

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
WGK (Water Danger/Protection)
CAS# 148901-52-4: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 148901-52-4 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 148901-52-4 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-氟-6-[4-(甲硫基)甲氧苯基]苄腈 在 间氯过氧苯甲酸 作用下， 以 二氯甲烷 为溶剂， 反应 2.0h， 生成 2-Fluoro-6-(4-methanesulfonyl-phenoxy)-benzonitrile
  参考文献：
  名称：

  [EN] INDAZOLE/PYRZOLO[4,3-c]PYRIDIN DERIVATIVES AS JNK INHIBITORS, COMPOSITIONS AND METHODS RELATED THERETO AS WELL AS INTERMEDIATE THEREOF
  [FR] DÉRIVÉS D'INDAZOLE/PYRZOLO[4,3-C]PYRIDINE UTILISÉS COMME INHIBITEURS DE JNK, COMPOSITIONS ET MÉTHODE S'Y RAPPORTANT ET PRODUITE INTERMÉDIAIRE

  摘要：

  本发明涉及公式（I）的新化合物，其中：X为CR4或N；R1为-OR5，-NHCOR6或-NR6R7；R2为氢，Oar1或-NHAr1，其中Ar1是芳基，可选择地取代一个或多个R8，-OR8，-NR8R9，-CONR8R9，-COOR8，-NR8COR9，-SR8，-SO2NR8R9，-NR8SO2R9，卤素，氰基或硝基；R3为氢或-NHAr2，其中Ar2是苯，可选择地取代一个或多个R8，-OR8，-NR8R9，卤素或硝基，其中R2和R3不同时为氢；一种制备它们的方法和在其中使用的新中间体，含有所述治疗活性化合物的制药配方以及所述活性化合物在治疗中的使用。

  公开号：

  WO2004113303A1

文献信息

• Electrooptic chromophores with large optical birefringence for applications at high speed and short wavelengths
  申请人：McGinniss D. Vincent

  公开号：US20060106262A1

  公开（公告）日：2006-05-18

  Disclosed is a series of materials, which exhibit large birefringence under the influence of an applied electric field. These materials are capable of switching this large birefringence with a characteristic time on the order of 1 microsecond or less. In addition, these materials have good optical loss at this wavelength, and are stable under irradiation. These materials are suitable for fabrication of optical devices such a variable optical attenuators, switches, and modulators that respond in these time frames or slower. These materials are also suitable for use across a wide range of wavelengths. As a second component of this invention, some of these novel materials exhibit these desired optical properties (large birefringence, low loss, stability under illumination) at wavelengths as short as about 400 nm. These materials are suitable for fabrication of optical devices operating at or about 405 nm, where conventional EO materials strongly absorb and/or quickly degrade.

  披露了一系列材料，这些材料在受到外加电场影响下表现出较大的双折射。这些材料能够在大约1微秒或更短的时间内切换这种较大的双折射。此外，这些材料在这个波长下具有良好的光学损耗，并且在辐照下稳定。这些材料适用于制造像可变光学衰减器、开关和调制器等在这些时间范围或更慢响应的光学器件。这些材料也适用于在广泛波长范围内使用。作为本发明的第二个组成部分，一些新型材料在约400纳米的波长下展现出这些理想的光学特性（较大的双折射、低损耗、辐照下的稳定性）。这些材料适用于制造在或约405纳米波长下运行的光学器件，传统的电光材料在这个波长下会强烈吸收和/或迅速降解。
• Synthesis of Diaryl Ethers, Diaryl Thioethers, and Diarylamines Mediated by Potassium Fluoride−Alumina and 18-Crown-6:  Expansion of Scope and Utility¹
  作者：J. Scott Sawyer、Elisabeth A. Schmittling、Jayne A. Palkowitz、William J. Smith

  DOI：10.1021/jo980800g

  日期：1998.9.1

  An efficient alternative to the Ullmann ether synthesis of diaryl ethers, diaryl thioethers, and diarylamines involving the SNAr addition of a phenol, thiophenol, or aniline to an appropriate aryl halide, mediated by potassium-fluoride alumina and 18-crown-6 in acetonitrile or DMSO, is described. Expansion of the reaction conditions to include DMSO as solvent has resulted in a far greater range of substitution patterns permitted on the electrophile. For example, it was found that electronically unfavorable S-chlorobenzonitrile could be condensed with 3-methoxyphenol to form the corresponding diaryl ether in 66% yield, a combination not normally amenable to Ullmann coupling. Electron-withdrawing groups present on the electrophile may be as diverse as nitro, cyano, formyl, acetyl, ester, amide, and even aryl. The method features a simple reaction procedure that provides products in generally good to excellent purified yields.
• [EN] INDAZOLE/PYRZOLO[4,3-c]PYRIDIN DERIVATIVES AS JNK INHIBITORS, COMPOSITIONS AND METHODS RELATED THERETO AS WELL AS INTERMEDIATE THEREOF<br/>[FR] DÉRIVÉS D'INDAZOLE/PYRZOLO[4,3-C]PYRIDINE UTILISÉS COMME INHIBITEURS DE JNK, COMPOSITIONS ET MÉTHODE S'Y RAPPORTANT ET PRODUITE INTERMÉDIAIRE
  申请人：ASTRAZENECA AB

  公开号：WO2004113303A1

  公开（公告）日：2004-12-29

  The present invention relates to new compounds of formula (I) in which:X is CR4 or N; R1 is -OR5, -NHCOR6 or -NR6R7; R2 is hydrogen, Oar1 or -NHAr1 wherein Ar1 is aryl optionally substituted with one or more of R8, -OR8, -NR8R9, -CONR8R9, -COOR8, -NR8COR9, -SR8, -SO2NR8R9, -NR8SO2 R9, halogen, cyano, or nitro; R3 is hydrogen or -NHAr2 wherein Ar2 is benzene optionally substituted with one or more of R8, -OR8, -NR8R9, halogen or nitro, wherein R2 and R3 is not simultaneously hydrogen; a process for their preparation and new intermediates used therein, pharmaceutical formulations containing said therapeutically active compounds and to the use of said active compounds in therapy.

  本发明涉及公式（I）的新化合物，其中：X为CR4或N；R1为-OR5，-NHCOR6或-NR6R7；R2为氢，Oar1或-NHAr1，其中Ar1是芳基，可选择地取代一个或多个R8，-OR8，-NR8R9，-CONR8R9，-COOR8，-NR8COR9，-SR8，-SO2NR8R9，-NR8SO2R9，卤素，氰基或硝基；R3为氢或-NHAr2，其中Ar2是苯，可选择地取代一个或多个R8，-OR8，-NR8R9，卤素或硝基，其中R2和R3不同时为氢；一种制备它们的方法和在其中使用的新中间体，含有所述治疗活性化合物的制药配方以及所述活性化合物在治疗中的使用。